Navidea Biopharmaceuticals Presents Favorable Comparison of Lymphoseek® to Sulfur Colloid at Sentinel Node Oncology Foundation and Sentinel Lymph Node Working Group Apr 3, 2012
Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Phase 3 Data at Society of Surgical Oncology Meeting Mar 28, 2012
Navidea Biopharmaceuticals to Announce Fourth-Quarter and Full-Year 2011 Financial Results on Thursday, March 1, 2012 Feb 27, 2012
Navidea President, Dr. Mark Pykett, to Participate in Panel Discussion on Companion Diagnostics at BIO CEO Feb 13, 2012
Navidea Obtains Positive EMA Guidance for Lymphoseek® (Tilmanocept); Company to Submit Marketing Authorization Application in Europe Feb 1, 2012
